Oligomerix at SfN 2026

Nov 14–18, 2026 Washington, DC ~21k attendees Website

Oligomerix brings 2 presentations to SfN 2026 in Washington. Its program at this meeting focuses on tau pathology and treatment strategies for Alzheimer’s disease in mouse models. One thread examines reductions in blood biomarkers of tau and inflammation following OLX-07010 treatment.

OrganizationSfN 2026 Attendance
Oligomerix
Bronx, NY
oligomerix.com
Drug developers
Biotechnology company developing therapies for neurodegenerative diseases, including Alzheimer’s disease.
Poster
Sun Nov 15
8am–noon
Poster
Mon Nov 16
8am–noon

Explore the full SfN 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Washington. Leave your work email and we’ll be in touch.

Privacy

Download the full SfN 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Oligomerix

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with the Society for Neuroscience. Organization details are derived from SfN’s published exhibitor list, its Neuroscience Meeting Planner and each organization’s own website. Submit a correction